Legal Medical Cannabis Means Better, Not Weaker, Health Protection
Dr. Julian Wichmann, MD, Co-Founder and CEO of Bloomwell GmbH Germany has, without question, the most progressive regulation of medical cannabis in the EU.
Dr. Julian Wichmann, MD, Co-Founder and CEO of Bloomwell GmbH Germany has, without question, the most progressive regulation of medical cannabis in the EU.
As the European cannabis conference season gets started, industry experts, lawmakers, regulators and business owners are facing greater mainstream scrutiny than ever before.
Next week will mark the second anniversary of the implementation of Germany’s landmark Cannabis Act (CanG), which came into force on April 01, 2024.
Germany’s cannabis imports, according to the latest figures from BfArM, nearly tripled in size in 2025, cementing it beyond any doubt as the engine behind Europe’s medical cannabis boom.
Germany’s imports for 2025 surpassed 200 tonnes for the first time, exceeding the country’s already revised import quota for the second time in a year.
As Trump’s rescheduling executive order dominated the cannabis industry’s attention over the holiday period, Germany’s controversial medical cannabis bill quietly entered its most critical phase.
Germany’s telemedicine-fuelled expansion has driven the value of its medical cannabis market up by hundreds of millions of euros in just less than two years.
Since Germany’s Cannabis Act (CanG) came into force on 1 April 2024, much has changed regarding what was once the country’s most widely used illegal drug.
This article is also available in German Germany’s new Federal Drug Commissioner, Prof Dr Hendrik Streeck (CDU), who in June had spoken only vaguely about the partial legalisation of cannabis, has since taken a sharper stance.